Ubs Etf USA Div Ar Esg Eur D logo

Ubs Etf USA Div Ar Esg Eur D (SPDE)

Market Open
29 Jun, 07:05
XMIL XMIL
3. 53
-0.04
-1.0224%
- Market Cap
- Div Yield
1,000 Volume
3.57
Previous Close
Add Transaction
Day Range
3.53 3.59
Year Range
3.16 3.59
Want to track SPDE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SPDE trading today lower at €3.53, a decrease of -1.0224% from yesterday's close, completing a monthly increase of 3.8349% or €0.13. Over the past 12 months, SPDE stock gained 7.4829%.
SPDE is not paying dividends to its shareholders.
Ubs Etf USA Div Ar Esg Eur D has completed 1 stock splits, with the recent split occurring on Dec 03, 2007.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

SPDE Chart

Ubs Etf USA Div Ar Esg Eur D (SPDE) FAQ

What is the stock price today?

The current price is €3.53.

On which exchange is it traded?

Ubs Etf USA Div Ar Esg Eur D is listed on XMIL.

What is its stock symbol?

The ticker symbol is SPDE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Ubs Etf USA Div Ar Esg Eur D ever had a stock split?

Ubs Etf USA Div Ar Esg Eur D had 1 splits and the recent split was on Dec 03, 2007.

Ubs Etf USA Div Ar Esg Eur D Profile

XMIL Exchange
US Country

Overview

Speedus Corp., originally established as SPEEDUS.COM, Inc., underwent a name change in May 2002 to reflect its evolved business scope. Founded in 1995, the company has its headquarters in Freehold, New Jersey. Its primary focus is on developing diagnostic decision support tools and telemedicine solutions aimed at enhancing medical practitioners' capabilities, including primary care physicians, pediatricians, and cardiologists, across the United States. Speedus Corp. operates through its subsidiaries, offering innovative medical devices and technology solutions that leverage computer-aided design and ultra-high speed storage systems. Besides its core healthcare technology products, the company is also engaged in managing a diverse portfolio of marketable securities, and equity and debt instruments in non-publicly traded companies. Furthermore, it holds a local multipoint distribution service license that boasts coverage of a substantial spectrum range in the New York City area, indicating a strategic asset within the telecommunications domain.

Products and Services

  • Zargis Cardioscan device

    This non-invasive diagnostic support tool is designed to revolutionize the way heart murmurs are detected and analyzed. By automatically examining acoustical data collected from a patient, the Cardioscan device can quickly determine the presence of a suspected diastolic or systolic murmur, streamlining the diagnostic process and enhancing patient care.

  • ZargisTelemed portal

    A telemedicine-based platform that provides an integrated solution for healthcare professionals to remotely diagnose and manage patient care. This portal is part of Speedus Corp.’s initiative to make healthcare more accessible and efficient by leveraging advanced technology.

  • Signal X6 device

    This innovative device captures heart and lung sounds through six adhesive acoustic sensors, offering a comprehensive tool for recording critical physiological data. The Signal X6 is a testament to Speedus Corp.'s commitment to advancing medical diagnostics through technology.

  • Ultra-high speed storage systems
    • JetX10 acceleration appliance
    • JetPod
    • JetNode expansion chassis

    Speedus Corp. also ventures into the development and marketing of cutting-edge storage solutions, aimed at bolstering server network performance and other applications. These products, including the JetX10 acceleration appliance, JetPod, and JetNode expansion chassis, embody the company’s dedication to innovation beyond the medical field, potentially serving various industries with ultra-high speed data storage capabilities.

  • Local multipoint distribution service license

    This special FCC commercial operating license allows Speedus Corp. exclusive access to a significant spectrum range, between 150–300 MHz, in the New York City area. This asset not only facilitates the company's telecommunication services but also represents a strategic advantage in the competitive market.

Contact Information

Address: 1 Dag Hammarskjold Boulevard
Phone: +1 718 767 7600